The role of Nrf2 in cancer is a little paradoxical, however, in T-cell lymphoma it is delimited to its traditional pathway where any deterioration in this pathway leads to carcinogenesis and restabilizing it results in the enhancement of lymphoma. The gene discussed is NFE2L2; the disease is T-cell non-Hodgkin lymphoma.